Latest News in Cancer
Stay updated with the most recent articles and resources.
Main Topics
The history and evolution of gene therapy
Gene therapy has truly traveled a distance—from its conceptual roots dating back to the mid-20th century to its modern claim to fame with CRISPR technology....
Gene therapy in China
Gene therapy in China is rapidly advancing because of massive investment in research and development. Equipped with state-of-the-art technology, such as CRISPR-Cas9, Chinese scientists lead...
First Gene Therapy for Children with Metachromatic Leukodystrophy is Approved by the FDA
FDA approval The U.S. Food and Drug Administration has granted Lenmeldy (atidarsagene autotemcel) approval. The FDA has approved this gene therapy as the first of...
FDA approves gene therapy to treat beta thalassemia
The FDA has approved a groundbreaking gene therapy to treat beta thalassemia, a genetic blood disorder that requires regular blood transfusions. This innovative therapy, called...
First gene therapy approved by the USFDA to treat sickle cell disease
USFDA approved gene therapy for sickle cell disease The U.S. Food and Drug Administration has granted approval for two significant medications, Casgevy and Lyfgenia, which...
Gene Therapy for Thalassemia
Gene therapy for thalassemia is a groundbreaking treatment that targets the genetic roots of the disease. By introducing functional copies of the beta-globin gene into...
Gene therapy for sickle cell anemia
Gene therapy for sickle cell anemia offers a promising solution by targeting the root cause of the disease. This innovative treatment involves modifying the patient's...
CAR T-Cell therapy for Chronic Lymphocytic Leukemia
Introduction Chronic lymphocytic leukemia (CLL) is a long-lasting condition where mature B lymphocytes, which have encountered antigens before, become cancerous. This leads to the buildup...
Adagrasib with cetuximab has received accelerated approval by FDA for KRAS G12C-mutated colorectal cancer
The FDA has granted accelerated approval to Adagrasib combined with Cetuximab for treating KRAS G12C-mutated colorectal cancer. This approval is based on promising clinical trial...
Pembrolizumab with chemotherapy is approved by the USFDA for primary advanced or recurrent endometrial carcinoma
The USFDA has approved Pembrolizumab combined with chemotherapy for treating primary advanced or recurrent endometrial carcinoma. This approval is based on clinical trial data showing...
Durvalumab with chemotherapy is approved by the USFDA for mismatch repair deficient primary advanced or recurrent endometrial cancer
The USFDA has approved Durvalumab combined with chemotherapy for treating mismatch repair-deficient primary advanced or recurrent endometrial cancer. This approval is based on clinical trials...
Repotrectinib has received accelerated approval from the USFDA for adult and pediatric patients with NTRK gene fusion-positive solid tumors
Repotrectinib has received accelerated approval for treating adult and pediatric patients with NTRK gene fusion-positive solid tumors. This approval, based on promising clinical trial results,...
Need help? Our team is ready to assist you.
We wish a speedy recovery for your loved ones.